What is Microsonic?
Microsonic operates as a premier full-service earmold laboratory, distinguished by its commitment to hand-crafted precision and material innovation. The company serves as a critical link in the audiology supply chain, providing bespoke earmolds, advanced fitting supplies, and specialized accessories. Beyond its core manufacturing capabilities, Microsonic maintains a robust Accessory Division, positioning itself as a leading global supplier of impression materials and preformed tubing. The firm's market authority is further cemented by a portfolio of patents, including the Tube Lock Plus and the Microsonic Universal Syringe, which demonstrate a consistent focus on technical advancement and clinical efficacy.
How much funding has Microsonic raised?
Microsonic has raised a total of $423K across 2 funding rounds:
Debt
$150K
Debt
$273K
Debt (2020): $150K with participation from PPP
Debt (2021): $273K led by PPP
Key Investors in Microsonic
PPP
Public-Private Partnership
What's next for Microsonic?
With the recent influx of capital, Microsonic is poised to transition into a new phase of operational expansion and technological integration. The strategic focus will likely center on scaling its R&D pipeline to introduce next-generation materials that enhance patient comfort and acoustic performance. Furthermore, the company is expected to leverage its strengthened balance sheet to optimize its supply chain logistics, ensuring that its extensive catalog of accessories remains readily available to a global network of dispensers. As the audiology industry evolves toward more integrated digital workflows, Microsonic's ability to blend traditional craftsmanship with modern material science will be the primary driver of its long-term growth and competitive differentiation.
See full Microsonic company page